Research ArticleAnthrax
Anthrax Vaccine–Induced Antibodies Provide Cross-Species Prediction of Survival to Aerosol Challenge
- Michael P. Fay1,*,
- Dean A. Follmann1,
- Freyja Lynn2,†,
- Jarad M. Schiffer3,‡,
- Gregory V. Stark4,
- Robert Kohberger5,§,
- Conrad P. Quinn3,‡ and
- Edwin O. Nuzum2
- 1Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, 6700B Rockledge Drive, Bethesda, MD 20892–7630, USA.
- 2Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, 6610 Rockledge Drive, Bethesda, MD 20892–6604, USA.
- 3Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30333, USA.
- 4Battelle, 505 King Avenue, Columbus, OH 43201, USA.
- 5Blair & Co., Greenwich, CT 06830, USA.
- ↵*To whom correspondence should be addressed. E-mail: mfay{at}niaid.nih.gov
-
↵† Present address: Center for Biologics Evaluation and Research, Office of Vaccines Research and Review, 9000 Rockville Pike, Bethesda, MD 20892, USA.
-
↵‡ The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention.
-
↵§ Deceased. We dedicate this paper to him.
See allHide authors and affiliations
Science Translational Medicine 12 Sep 2012:
Vol. 4, Issue 151, pp. 151ra126
DOI: 10.1126/scitranslmed.3004073
